Petros Pharmaceuticals In...

AI Score

0

Unlock

0.30
-0.01 (-3.38%)
At close: Jan 15, 2025, 10:25 AM

Petros Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Mar 31, 2023Sep 30, 2022
Medical Devices Revenue 718.30K 806.45K 775.71K 2.52M 1.01M 682.90K
Medical Devices Revenue Growth -10.93% +3.96% -69.27% +149.51% +48.15% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
International Revenue 1.30M 4.80M 6.57M
International Revenue Growth -73.00% -26.99% n/a
United States Revenue 4.53M n/a n/a
United States Revenue Growth n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019
Selling, General, and Administrative Revenue 2.30M 2.29M 2.71M 2.88M 2.00M 2.25M 2.13M 2.92M 2.17M 3.22M 3.90M 4.18M 3.41M 4.12M 3.88M 3.68M 3.12M 4.06M 4.82M 4.03M 5.63M 5.67M 4.39M
Selling, General, and Administrative Revenue Growth +0.64% -15.67% -5.83% +43.83% -11.01% +5.58% -27.13% +34.68% -32.51% -17.48% -6.80% +22.53% -17.08% +6.04% +5.55% +17.84% -23.12% -15.71% +19.45% -28.43% -0.71% +29.32% n/a
Research and Development Revenue 588.36K 368.80K 1.56M 834.33K 389.09K 866.58K 319.09K 177.76K 735.92K 421.24K 405.36K 988.69K 280.58K 500.05K 19.18K 151.84K 36.83K 131.58K 139.38K n/a n/a n/a n/a
Research and Development Revenue Growth +59.53% -76.30% +86.49% +114.43% -55.10% +171.57% +79.51% -75.84% +74.70% +3.92% -59.00% +252.38% -43.89% +2506.99% -87.37% +312.29% -72.01% -5.60% n/a n/a n/a n/a n/a